Pankaj Malhotra

ORCID: 0000-0003-1198-8491 · 3 papers in corpus
nonrandomized-trial 2025
Danazol causes significant changes in the cardiometabolic profile of patients with acquired aplastic anaemia
Blood cells, molecules & diseases ·doi:10.1016/j.bcmd.2025.102921

BACKGROUND: Danazol is frequently used in treating patients with acquired aplastic anaemia (AA) in resource-constraint settings. We aimed to evaluate the cardiometabolic side effects of Danazol in patients with AA. METHODS: This prospectiv…

observational 2025
Impact of Dasatinib on Female Reproductive Health in Philadelphia-Positive Leukemia Patients
Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion ·doi:10.1007/s12288-024-01932-6

Tyrosine kinase inhibitors (TKIs) have revolutionized the treatment of chronic myeloid leukemia (CML), with patients now achieving life expectancy comparable to the general population. Despite the contraindication of TKIs during the first t…

other 2018
Danazol increases T regulatory cells in patients with aplastic anemia
Hematology (Amsterdam, Netherlands) ·doi:10.1080/10245332.2018.1435045

OBJECTIVES: Danazol is an attenuated androgen and is used in the treatment of aplastic anemia (AA) in resource constraint settings. We chose to study the role of CD4+ CD25high CD127low FoxP3+ T regulatory cells (T-regs) in the pathophysiolo…